OTC Markets EXMKT - Delayed Quote USD
GB Sciences, Inc. (GBLX)
0.0002
0.0000
(0.00%)
At close: April 23 at 1:51:45 PM EDT
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Andrea Small-Howard M.B.A., MBA, Ph.D. | Chairman of Scientific Advisory Board, Chief Science Officer, President & Director | 144k | -- | 1969 |
GB Sciences, Inc.
9205 W. Russell Road
Suite 240
Las Vegas, NV 89148
United States
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 2
Description
GB Sciences, Inc., a plant-based research and biopharmaceutical drug development company. The company offers cannabis inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of medical conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, cytokine release syndrome, stress/anxiety/depression, and cardiovascular therapeutic programs. The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Sciences, Inc. in October 2016. GB Sciences, Inc. is based in Las Vegas, Nevada.
Corporate Governance
GB Sciences, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
February 13, 2025 at 9:00 PM UTC - February 14, 2025 at 9:00 PM UTC
GB Sciences, Inc. Earnings Date
Recent Events
Related Tickers
CNBX CNBX Pharmaceuticals Inc.
0.0039
-4.88%
NTRB Nutriband Inc.
5.23
+3.36%
PPCB Propanc Biopharma, Inc.
6.46
+17.45%
MBRX Moleculin Biotech, Inc.
1.0300
-1.90%
BMRN BioMarin Pharmaceutical Inc.
61.94
+0.72%
PSTV Plus Therapeutics, Inc.
0.9835
+24.97%
RXRX Recursion Pharmaceuticals, Inc.
5.58
-0.89%